BioXcel Restructuring Monday, August 24, 2026 0.00 Neutral

Lenders extend deadlines for potential resolution under credit agreement

BioXcel Therapeutics lenders have amended their credit agreement to extend March 31 deadlines, now allowing for an acceptable transaction to be completed on or prior to August 28, 2026.

View original filing at SEC.gov →
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.

Get real-time financial news in your trading bot or app

GET FREE KEY — 10,000 calls/day